Nanoparticle compositions for sustained therapy
US12011480B2 · kind B2 · utility
1Cited by
62References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 6, 2016 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Apr 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides compositions and methods for promoting the formation, expansion and recruitment of TR1 cells and/or B cells in an antigen-specific manner and treating diseases and disorders in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.